MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...

Reported last patient, last visit in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with early-stage dementia with Lewy bodies (DLB) in October 2024; topline data expected ...

Reported last patient, last visit in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with early-stage dementia with Lewy bodies (DLB) in October 2024; topline data expected ...

The market expects Dolby Laboratories (DLB) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known ...

The Prix Galien USA Best Startup category recognizes outstanding innovation by therapeutics-focused life science companies that have not yet received their first product approval The award to CervoMed ...

The growing demand for smart home devices and the adoption of the latest technologies is increasing the demand for consumer ...

Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia, improved ...

Louisiana State Employees Retirement System decreased its stake in Dolby Laboratories, Inc. (NYSE:DLB – Free Report) by 2.4% ...

Baseline characteristics of the 130 participants enrolled in the study, as described in the poster: “DLB is one of the most common forms of dementia and a complex neurological condition. Symptoms ...

Superstars Gerrit Cole, Aaron Judge shine in Game 5 spotlight as the Yankees shut out the Dodgers 2-0 in our simulation.

Opens in a new tab or window The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes ...

Here’s the story of the 2024 Des Lacs-Burlington Lady Lakers. When DLB girls golf teed off its season on Aug. 9, the squad had no idea it was less than two months away from a feat nearly three ...